|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Stock Screener |
Insider Trading Graph View |
Insider Watch |
Insider Trading - Vanda Pharmaceuticals Inc. (VNDA)
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2019-08-26 Sale |
2019-08-28 4:30 pm |
Vanda Pharmaceuticals Inc. | VNDA | DUGAN RICHARD W Director |
15,000 | $14.85 | $222,750 | 50,770 (Direct) |
View |
| 2019-08-14 Sale |
2019-08-15 4:58 pm |
Vanda Pharmaceuticals Inc. | VNDA | Williams Timothy VP |
2,575 | $14.69 | $37,829 | 57,425 (Direct) |
View |
| 2019-05-17 Sale |
2019-05-21 5:02 pm |
Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos CEO |
217,515 | $15.35 | $3,338,725 | 1,284,327 (Direct) |
View |
| 2019-03-01 Sale |
2019-03-04 5:12 pm |
Vanda Pharmaceuticals Inc. | VNDA | Reverberi Gian Piero SVP & Chief Commercial Officer |
881 | $20.04 | $17,655 | 168,432 (Direct) |
View |
| 2019-03-01 Sale |
2019-03-04 5:10 pm |
Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos CEO |
44,666 | $19.53 | $872,226 | 1,217,136 (Direct) |
View |
| 2019-03-01 Sale |
2019-03-04 5:06 pm |
Vanda Pharmaceuticals Inc. | VNDA | Kelly James Patrick CFO |
13,727 | $19.98 | $274,232 | 218,497 (Direct) |
View |
| 2019-03-01 Sale |
2019-03-04 5:02 pm |
Vanda Pharmaceuticals Inc. | VNDA | Birznieks Gunther VP |
12,529 | $19.96 | $250,092 | 160,039 (Direct) |
View |
| 2019-01-02 Sale |
2019-01-04 4:37 pm |
Vanda Pharmaceuticals Inc. | VNDA | Reverberi Gian Piero SVP & Chief Commercial Officer |
1,130 | $26.59 | $30,042 | 139,400 (Direct) |
View |
| 2019-01-02 Sale |
2019-01-04 4:34 pm |
Vanda Pharmaceuticals Inc. | VNDA | Birznieks Gunther VP |
6,061 | $26.37 | $159,810 | 136,569 (Direct) |
View |
| 2019-01-02 Sale |
2019-01-04 4:33 pm |
Vanda Pharmaceuticals Inc. | VNDA | Kelly James Patrick CFO |
6,061 | $26.37 | $159,811 | 196,221 (Direct) |
View |
| 2019-01-02 Sale |
2019-01-04 4:31 pm |
Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos CEO |
15,236 | $26.36 | $401,663 | 1,178,872 (Direct) |
View |
| 2018-02-28 Sale |
2018-03-02 5:36 pm |
Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos CEO |
60,966 | $18.72 | $1,141,003 | 1,243,838 (Direct) |
View |
| 2018-02-28 Sale |
2018-03-02 5:34 pm |
Vanda Pharmaceuticals Inc. | VNDA | Kelly James Patrick CFO |
8,532 | $18.72 | $159,712 | 208,066 (Direct) |
View |
| 2018-02-28 Sale |
2018-03-02 5:33 pm |
Vanda Pharmaceuticals Inc. | VNDA | Gulino Richard L. VP |
3,660 | $18.71 | $68,473 | 118,733 (Direct) |
View |
| 2018-02-28 Sale |
2018-03-02 5:32 pm |
Vanda Pharmaceuticals Inc. | VNDA | Birznieks Gunther VP |
8,525 | $18.72 | $159,605 | 148,366 (Direct) |
View |
| 2018-01-02 Sale |
2018-01-04 5:13 pm |
Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos CEO |
191,760 | $15.3 | $2,933,127 | 1,281,848 (Direct) |
View |
| 2018-01-02 Sale |
2018-01-04 5:12 pm |
Vanda Pharmaceuticals Inc. | VNDA | Kelly James Patrick CFO |
9,155 | $15.35 | $140,494 | 177,221 (Direct) |
View |
| 2018-01-02 Sale |
2018-01-04 5:11 pm |
Vanda Pharmaceuticals Inc. | VNDA | Gulino Richard L. VP |
10,367 | $15.2 | $157,565 | 99,100 (Direct) |
View |
| 2018-01-02 Sale |
2018-01-04 5:09 pm |
Vanda Pharmaceuticals Inc. | VNDA | Birznieks Gunther VP |
8,568 | $15.26 | $130,777 | 118,366 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2019-10-28 Option Award |
2019-10-28 9:47 pm |
N/A 2029-10-27 |
Vanda Pharmaceuticals Inc. | VNDA | Ward Anne Sempowski Director |
35,000 | $14.21 | 35,000 (Direct) |
View |
| 2019-08-26 Exercise |
2019-08-28 4:30 pm |
N/A N/A |
Vanda Pharmaceuticals Inc. | VNDA | DUGAN RICHARD W Director |
15,000 | $14.78 | 50,770 (Direct) |
View |
| 2019-08-26 Exercise |
2019-08-28 4:30 pm |
N/A 2019-08-26 |
Vanda Pharmaceuticals Inc. | VNDA | DUGAN RICHARD W Director |
15,000 | $14.78 | 50,770 (Direct) |
View |
| 2019-08-19 Option Award |
2019-08-21 4:52 pm |
N/A N/A |
Vanda Pharmaceuticals Inc. | VNDA | Wijkstrom Joakim SVP Chief Marketing Officer |
30,000 | $0 | 90,000 (Direct) |
View |
| 2019-08-19 Option Award |
2019-08-21 4:52 pm |
N/A 2029-08-18 |
Vanda Pharmaceuticals Inc. | VNDA | Wijkstrom Joakim SVP Chief Marketing Officer |
90,000 | $15.33 | 90,000 (Direct) |
View |
| 2019-06-13 Option Award |
2019-06-17 5:03 pm |
N/A N/A |
Vanda Pharmaceuticals Inc. | VNDA | Watkins Thomas Director |
5,000 | $0 | 30,000 (Direct) |
View |
| 2019-06-13 Option Award |
2019-06-17 5:03 pm |
N/A 2029-06-12 |
Vanda Pharmaceuticals Inc. | VNDA | Watkins Thomas Director |
10,000 | $15.04 | 30,000 (Direct) |
View |
| 2019-06-13 Option Award |
2019-06-17 5:03 pm |
N/A N/A |
Vanda Pharmaceuticals Inc. | VNDA | DUGAN RICHARD W Director |
5,000 | $0 | 35,770 (Direct) |
View |
| 2019-06-13 Option Award |
2019-06-17 5:03 pm |
N/A 2029-06-12 |
Vanda Pharmaceuticals Inc. | VNDA | DUGAN RICHARD W Director |
10,000 | $15.04 | 35,770 (Direct) |
View |
| 2019-06-13 Option Award |
2019-06-17 5:02 pm |
N/A N/A |
Vanda Pharmaceuticals Inc. | VNDA | COLA MICHAEL F Director |
5,000 | $0 | 15,000 (Direct) |
View |
| 2019-06-13 Option Award |
2019-06-17 5:02 pm |
N/A 2029-06-12 |
Vanda Pharmaceuticals Inc. | VNDA | COLA MICHAEL F Director |
10,000 | $15.04 | 15,000 (Direct) |
View |
| 2019-06-13 Option Award |
2019-06-17 5:01 pm |
N/A N/A |
Vanda Pharmaceuticals Inc. | VNDA | Chrousos Phaedra Director |
5,000 | $0 | 10,000 (Direct) |
View |
| 2019-06-13 Option Award |
2019-06-17 5:01 pm |
N/A 2029-06-12 |
Vanda Pharmaceuticals Inc. | VNDA | Chrousos Phaedra Director |
10,000 | $15.04 | 10,000 (Direct) |
View |
| 2019-05-17 Exercise |
2019-05-21 5:02 pm |
N/A N/A |
Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos CEO |
97,373 | $12.55 | 1,284,327 (Direct) |
View |
| 2019-05-17 Exercise |
2019-05-21 5:02 pm |
N/A N/A |
Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos CEO |
73,608 | $12.55 | 1,284,327 (Direct) |
View |
| 2019-05-17 Exercise |
2019-05-21 5:02 pm |
N/A N/A |
Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos CEO |
79,019 | $12.55 | 1,284,327 (Direct) |
View |
| 2019-05-17 Exercise |
2019-05-21 5:02 pm |
N/A 2019-05-21 |
Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos CEO |
97,373 | $12.55 | 1,284,327 (Direct) |
View |
| 2019-05-17 Exercise |
2019-05-21 5:02 pm |
N/A 2019-05-21 |
Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos CEO |
73,608 | $12.55 | 1,284,327 (Direct) |
View |
| 2019-05-17 Exercise |
2019-05-21 5:02 pm |
N/A 2019-05-21 |
Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos CEO |
79,019 | $12.55 | 1,284,327 (Direct) |
View |
| 2019-04-23 Option Award |
2019-04-24 5:34 pm |
N/A 2029-04-22 |
Vanda Pharmaceuticals Inc. | VNDA | Chrousos Phaedra Director |
35,000 | $17.31 | 35,000 (Direct) |
View |
| 2019-02-27 Option Award |
2019-03-01 4:27 pm |
N/A N/A |
Vanda Pharmaceuticals Inc. | VNDA | Williams Timothy VP |
30,000 | $0 | 70,000 (Direct) |
View |
| 2019-02-27 Option Award |
2019-03-01 4:27 pm |
N/A 2029-02-26 |
Vanda Pharmaceuticals Inc. | VNDA | Williams Timothy VP |
70,000 | $20.62 | 70,000 (Direct) |
View |
| 2019-02-27 Option Award |
2019-03-01 4:25 pm |
N/A N/A |
Vanda Pharmaceuticals Inc. | VNDA | Reverberi Gian Piero SVP & Chief Commercial Officer |
30,000 | $0 | 168,870 (Direct) |
View |
| 2019-02-27 Option Award |
2019-03-01 4:25 pm |
N/A 2029-02-26 |
Vanda Pharmaceuticals Inc. | VNDA | Reverberi Gian Piero SVP & Chief Commercial Officer |
70,000 | $20.62 | 168,870 (Direct) |
View |
| 2019-02-27 Option Award |
2019-03-01 4:22 pm |
N/A N/A |
Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos CEO |
60,000 | $0 | 1,223,636 (Direct) |
View |
| 2019-02-27 Option Award |
2019-03-01 4:22 pm |
N/A 2029-02-26 |
Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos CEO |
140,000 | $20.62 | 1,223,636 (Direct) |
View |
| 2019-02-27 Option Award |
2019-03-01 4:19 pm |
N/A N/A |
Vanda Pharmaceuticals Inc. | VNDA | Kelly James Patrick CFO |
30,000 | $0 | 223,473 (Direct) |
View |
| 2019-02-27 Option Award |
2019-03-01 4:19 pm |
N/A 2029-02-26 |
Vanda Pharmaceuticals Inc. | VNDA | Kelly James Patrick CFO |
70,000 | $20.62 | 223,473 (Direct) |
View |
| 2019-02-27 Option Award |
2019-03-01 4:18 pm |
N/A N/A |
Vanda Pharmaceuticals Inc. | VNDA | Birznieks Gunther VP |
30,000 | $0 | 163,780 (Direct) |
View |
| 2019-02-27 Option Award |
2019-03-01 4:18 pm |
N/A 2029-02-26 |
Vanda Pharmaceuticals Inc. | VNDA | Birznieks Gunther VP |
70,000 | $20.62 | 163,780 (Direct) |
View |
| 2019-01-02 Gift |
2019-01-04 4:31 pm |
N/A N/A |
Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos CEO |
4,000 | $0 | 1,178,872 (Direct) |
View |
| 2018-08-13 Option Award |
2018-08-14 5:06 pm |
N/A N/A |
Vanda Pharmaceuticals Inc. | VNDA | Williams Timothy VP |
30,000 | $0 | 90,000 (Direct) |
View |
| 2018-08-13 Option Award |
2018-08-14 5:06 pm |
N/A 2028-08-12 |
Vanda Pharmaceuticals Inc. | VNDA | Williams Timothy VP |
90,000 | $21.45 | 90,000 (Direct) |
View |
| 2018-06-13 Option Award |
2018-06-15 4:32 pm |
N/A N/A |
Vanda Pharmaceuticals Inc. | VNDA | COLA MICHAEL F Director |
5,000 | $0 | 10,000 (Direct) |
View |
| 2018-06-13 Option Award |
2018-06-15 4:32 pm |
N/A 2028-06-12 |
Vanda Pharmaceuticals Inc. | VNDA | COLA MICHAEL F Director |
10,000 | $18.3 | 10,000 (Direct) |
View |
| 2018-06-13 Option Award |
2018-06-15 4:31 pm |
N/A N/A |
Vanda Pharmaceuticals Inc. | VNDA | DUGAN RICHARD W Director |
5,000 | $0 | 30,770 (Direct) |
View |
| 2018-06-13 Option Award |
2018-06-15 4:31 pm |
N/A 2028-06-12 |
Vanda Pharmaceuticals Inc. | VNDA | DUGAN RICHARD W Director |
10,000 | $18.3 | 30,770 (Direct) |
View |
| 2018-06-13 Option Award |
2018-06-15 4:30 pm |
N/A N/A |
Vanda Pharmaceuticals Inc. | VNDA | MILANO VINCENT Director |
5,000 | $0 | 10,000 (Direct) |
View |
| 2018-06-13 Option Award |
2018-06-15 4:30 pm |
N/A 2028-06-12 |
Vanda Pharmaceuticals Inc. | VNDA | MILANO VINCENT Director |
10,000 | $18.3 | 10,000 (Direct) |
View |
| 2018-06-13 Option Award |
2018-06-15 4:30 pm |
N/A N/A |
Vanda Pharmaceuticals Inc. | VNDA | Watkins Thomas Director |
5,000 | $0 | 25,000 (Direct) |
View |
| 2018-06-13 Option Award |
2018-06-15 4:30 pm |
N/A 2028-06-12 |
Vanda Pharmaceuticals Inc. | VNDA | Watkins Thomas Director |
10,000 | $18.3 | 25,000 (Direct) |
View |
| 2018-05-03 Exercise |
2018-05-04 4:06 pm |
N/A N/A |
Vanda Pharmaceuticals Inc. | VNDA | Watkins Thomas Director |
15,000 | $4.98 | 20,000 (Direct) |
View |
| 2018-05-03 Exercise |
2018-05-04 4:06 pm |
N/A 2018-05-07 |
Vanda Pharmaceuticals Inc. | VNDA | Watkins Thomas Director |
15,000 | $4.98 | 20,000 (Direct) |
View |
| 2018-03-19 Exercise |
2018-03-20 5:02 pm |
N/A N/A |
Vanda Pharmaceuticals Inc. | VNDA | DUGAN RICHARD W Director |
15,000 | $4.98 | 25,770 (Direct) |
View |
| 2018-03-19 Exercise |
2018-03-20 5:02 pm |
N/A 2018-05-07 |
Vanda Pharmaceuticals Inc. | VNDA | DUGAN RICHARD W Director |
15,000 | $4.98 | 25,770 (Direct) |
View |
| 2018-02-28 Option Award |
2018-03-02 5:37 pm |
N/A N/A |
Vanda Pharmaceuticals Inc. | VNDA | Reverberi Gian Piero SVP & Chief Commercial Officer |
30,000 | $0 | 140,000 (Direct) |
View |
| 2018-02-28 Option Award |
2018-03-02 5:37 pm |
N/A 2028-02-27 |
Vanda Pharmaceuticals Inc. | VNDA | Reverberi Gian Piero SVP & Chief Commercial Officer |
70,000 | $18.85 | 140,000 (Direct) |
View |
| 2018-02-28 Option Award |
2018-03-02 5:36 pm |
N/A N/A |
Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos CEO |
60,000 | $0 | 1,243,838 (Direct) |
View |
| 2018-02-28 Option Award |
2018-03-02 5:36 pm |
N/A 2028-02-27 |
Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos CEO |
140,000 | $18.85 | 1,243,838 (Direct) |
View |
| 2018-02-28 Option Award |
2018-03-02 5:34 pm |
N/A N/A |
Vanda Pharmaceuticals Inc. | VNDA | Kelly James Patrick CFO |
40,000 | $0 | 208,066 (Direct) |
View |
| 2018-02-28 Option Award |
2018-03-02 5:34 pm |
N/A 2028-02-27 |
Vanda Pharmaceuticals Inc. | VNDA | Kelly James Patrick CFO |
80,000 | $18.85 | 208,066 (Direct) |
View |
| 2018-02-28 Option Award |
2018-03-02 5:33 pm |
N/A N/A |
Vanda Pharmaceuticals Inc. | VNDA | Gulino Richard L. VP |
30,000 | $0 | 118,733 (Direct) |
View |
| 2018-02-28 Option Award |
2018-03-02 5:33 pm |
N/A 2028-02-27 |
Vanda Pharmaceuticals Inc. | VNDA | Gulino Richard L. VP |
70,000 | $18.85 | 118,733 (Direct) |
View |
| 2018-02-28 Option Award |
2018-03-02 5:32 pm |
N/A N/A |
Vanda Pharmaceuticals Inc. | VNDA | Birznieks Gunther VP |
30,000 | $0 | 148,366 (Direct) |
View |
| 2018-02-28 Option Award |
2018-03-02 5:32 pm |
N/A 2028-02-27 |
Vanda Pharmaceuticals Inc. | VNDA | Birznieks Gunther VP |
70,000 | $18.85 | 148,366 (Direct) |
View |
| 2018-01-02 Exercise |
2018-01-04 5:14 pm |
N/A N/A |
Vanda Pharmaceuticals Inc. | VNDA | Reverberi Gian Piero SVP & Chief Commercial Officer |
12,500 | $0 | 110,000 (Direct) |
View |
| 2018-01-02 Exercise |
2018-01-04 5:14 pm |
N/A N/A |
Vanda Pharmaceuticals Inc. | VNDA | Reverberi Gian Piero SVP & Chief Commercial Officer |
7,500 | $0 | 110,000 (Direct) |
View |
| 2018-01-02 Exercise |
2018-01-04 5:14 pm |
N/A N/A |
Vanda Pharmaceuticals Inc. | VNDA | Reverberi Gian Piero SVP & Chief Commercial Officer |
12,500 | $0 | 110,000 (Direct) |
View |
| 2018-01-02 Exercise |
2018-01-04 5:14 pm |
N/A N/A |
Vanda Pharmaceuticals Inc. | VNDA | Reverberi Gian Piero SVP & Chief Commercial Officer |
7,500 | $0 | 110,000 (Direct) |
View |
| 2018-01-02 Gift |
2018-01-04 5:13 pm |
N/A N/A |
Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos CEO |
10,000 | $0 | 1,281,848 (Direct) |
View |
| 2018-01-02 Exercise |
2018-01-04 5:13 pm |
N/A N/A |
Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos CEO |
250,000 | $5.76 | 1,281,848 (Direct) |
View |
| 2018-01-02 Exercise |
2018-01-04 5:13 pm |
N/A N/A |
Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos CEO |
12,500 | $0 | 1,281,848 (Direct) |
View |
| 2018-01-02 Exercise |
2018-01-04 5:13 pm |
N/A N/A |
Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos CEO |
12,500 | $0 | 1,281,848 (Direct) |
View |
| 2018-01-02 Exercise |
2018-01-04 5:13 pm |
N/A N/A |
Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos CEO |
18,750 | $0 | 1,281,848 (Direct) |
View |
| 2018-01-02 Exercise |
2018-01-04 5:13 pm |
N/A 2018-01-03 |
Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos CEO |
250,000 | $5.76 | 1,281,848 (Direct) |
View |
| 2018-01-02 Exercise |
2018-01-04 5:13 pm |
N/A N/A |
Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos CEO |
12,500 | $0 | 1,281,848 (Direct) |
View |
| 2018-01-02 Exercise |
2018-01-04 5:13 pm |
N/A N/A |
Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos CEO |
12,500 | $0 | 1,281,848 (Direct) |
View |
| 2018-01-02 Exercise |
2018-01-04 5:13 pm |
N/A N/A |
Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos CEO |
18,750 | $0 | 1,281,848 (Direct) |
View |
| 2018-01-02 Exercise |
2018-01-04 5:12 pm |
N/A N/A |
Vanda Pharmaceuticals Inc. | VNDA | Kelly James Patrick CFO |
5,000 | $0 | 177,221 (Direct) |
View |
| 2018-01-02 Exercise |
2018-01-04 5:12 pm |
N/A N/A |
Vanda Pharmaceuticals Inc. | VNDA | Kelly James Patrick CFO |
5,000 | $0 | 177,221 (Direct) |
View |
| 2018-01-02 Exercise |
2018-01-04 5:12 pm |
N/A N/A |
Vanda Pharmaceuticals Inc. | VNDA | Kelly James Patrick CFO |
7,500 | $0 | 177,221 (Direct) |
View |
| 2018-01-02 Exercise |
2018-01-04 5:12 pm |
N/A N/A |
Vanda Pharmaceuticals Inc. | VNDA | Kelly James Patrick CFO |
5,000 | $0 | 177,221 (Direct) |
View |
| 2018-01-02 Exercise |
2018-01-04 5:12 pm |
N/A N/A |
Vanda Pharmaceuticals Inc. | VNDA | Kelly James Patrick CFO |
5,000 | $0 | 177,221 (Direct) |
View |
| 2018-01-02 Exercise |
2018-01-04 5:12 pm |
N/A N/A |
Vanda Pharmaceuticals Inc. | VNDA | Kelly James Patrick CFO |
7,500 | $0 | 177,221 (Direct) |
View |
| 2018-01-02 Exercise |
2018-01-04 5:11 pm |
N/A N/A |
Vanda Pharmaceuticals Inc. | VNDA | Gulino Richard L. VP |
12,500 | $0 | 99,100 (Direct) |
View |
| 2018-01-02 Exercise |
2018-01-04 5:11 pm |
N/A N/A |
Vanda Pharmaceuticals Inc. | VNDA | Gulino Richard L. VP |
7,500 | $0 | 99,100 (Direct) |
View |
| 2018-01-02 Exercise |
2018-01-04 5:11 pm |
N/A N/A |
Vanda Pharmaceuticals Inc. | VNDA | Gulino Richard L. VP |
12,500 | $0 | 99,100 (Direct) |
View |
| 2018-01-02 Exercise |
2018-01-04 5:11 pm |
N/A N/A |
Vanda Pharmaceuticals Inc. | VNDA | Gulino Richard L. VP |
7,500 | $0 | 99,100 (Direct) |
View |
|
© 2005-2019 SecForm4.Com All rights reserved. Archives: 2019 2018 2017 2016 2015 2014 ... Mon, 11 Nov 2019 19:36:04 -0600 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |